About Ginolis
Ginolis is a company based in Oulunsalo (Finland) founded in 2010 was acquired by CELLINK in February 2021. Ginolis has raised $2.41 million across 4 funding rounds from investors including CELLINK, European Union and Verso Capital. Ginolis offers products and services including PMBi Dispensing Pump, Cecilia-L Dispenser, Ginolis LFDA-1, and Kaiku Data Collection Service. Ginolis operates in a competitive market with competitors including Opentrons, LabCyte, Tecan, Transcriptic and Andrew Alliance, among others.
- Headquarter Oulunsalo, Finland
- SectorsHealthcareIndustrial Goods & Manufacturing
- Email••••••••
- Website ginolis.com
- Social LinkedIn X YouTube
- Acquired by CELLINK (Feb 2021)
- Legal Name Ginolis Oy
Products & Services of Ginolis
Ginolis offers a comprehensive portfolio of products and services, including PMBi Dispensing Pump, Cecilia-L Dispenser, Ginolis LFDA-1, and Kaiku Data Collection Service.
High precision pump for non-contact liquid handling in manufacturing.
Automated dispenser for microfluidic device production processes.
Module for manufacturing lateral flow diagnostic tests efficiently.
Software for insights into manufacturing processes and optimization.
Apps and channels of Ginolis
its YouTube channel Ginolis Ltd has 313 subscribers and 16 videos.
Videos from Ginolis
The most watched videos on Ginolis's YouTube channel, Ginolis Ltd (313 subscribers). Click a video to play it here.
More on Ginolis Ltd.
Funding Insights of Ginolis
Ginolis has successfully raised a total of $2.41M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $571.61 thousand completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.41M
- Total Rounds 4
- Last Round Grant — $571,607
- First Round $451,500
(May 2015)
- Investors Count 3
All 4 funding rounds of Ginolis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $571,607 | Grant | – | – | |
| Feb 2017 | – | Series A | – | Verso Capital | – |
| Sep 2016 | $2.41M | Seed | – | – | |
| May 2015 | $451,500 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Ginolis
Ginolis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include CELLINK, European Union and Verso Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Buyouts are targeted by this private equity firm. | – | versocapital.com | Helsinki, Finland | |
Springvest is recognized as a leading growth investment service in Finland. | 2012 | springvest.fi | Helsinki, Finland | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
3D bioprinters and bioinks are developed for research applications. | 2016 | cellink.com | Boston, United States |
Investor details for Ginolis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ginolis
10 people are tracked at Ginolis (3 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Kauko Väinämö | Chief Executive Officer | Leadership |
Mika Kivela | Director, PMO And Sales Europe & Asia At Ginolis Ltd. | Leadership |
Juho Helminen | Chief Engineer | Leadership |
Bennett Grothaus | Application Engineer | Team |
Henri Westman | Commissioning Engineer | Team |
Ian Walker | Key Account Manager | Team |
Tuija Isomursu | HR Manager | Team |
Jari Mäkelä | Mechanic Engineering | Team |
Damian Wysocki | Automation Engineer | Team |
Reijo Heikkinen | Service Engineer | Team |
Complete people profiles for Ginolis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ginolis
4 dated milestones of Ginolis across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Ginolis is founded.
- Funding First funding round of $452K.
- Funding Latest funding round, Grant, of $572K.
- Exit Acquired by CELLINK.
Competitors of Ginolis
Ginolis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Opentrons, LabCyte, Tecan, Transcriptic and Andrew Alliance, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| opentrons.com | 2013 | Brooklyn, United States | $240.56M | 177 | Pipetting robots for laboratory automation are developed. | |
| labcyte.com | 2000 | Sunnyvale, United States | $33.39M | 184 | Acoustic liquid handling is developed for life science research. | |
| tecan.com | 1980 | Mannedorf, Switzerland | – | – | Automated laboratory instruments, robotics, and diagnostic solutions are provided. | |
| transcriptic.com | 2012 | Menlo Park, United States | $27.7M | 107 | Cloud-based robotic bio-lab services are delivered remotely for experiment execution. | |
| andrewalliance.com | 2011 | Vernier, Switzerland | $14.03M | 5 | Provider of automated liquid handling tools and software for scientific labs | |
| reshapebiotech.com | 2018 | Kongens Lyngby, Denmark | $29.23M | 16 | Scalable robotic platforms are provided for microbiology lab automation. | |
| scienion.com | 2000 | Berlin, Germany | $5.67M | 114 | Non-contact dispensing solutions for genomics and proteomics are provided. | |
| megarobo.com | 2016 | Singapore | $427.26M | – | Robotic solutions for industrial laboratory automation are provided by MEGAROBO. | |
| automata.tech | 2015 | London, United Kingdom | $106.51M | 151 | Lab automation robots are provided for life sciences applications. |
Detailed competitors of Ginolis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ginolis
Complete news archive for Ginolis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Ginolis
10 companies that operate in the same segment as Ginolis (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ginolis
Ginolis was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Ginolis is headquartered in Oulunsalo, Finland. It is registered at Oulunsalo, Northern Ostrobothnia, Finland.
Ginolis is a funded company, having raised a total of $2.41M across 4 funding rounds to date. The company's 1st funding round was a Grant of $451.5K, raised on May 2015.
Ginolis was established in 2010 in Oulunsalo, Finland, focusing on the life sciences and healthcare sectors. Liquid handling robots are produced for laboratory applications, enabling tasks including micro assembly, lateral flow device assembly, quality control, and automation design. The Delilah platform serves as a versatile system for diagnostic test manufacturing and lab processes, functioning independently or within integrated robotic setups. Operations center on enhancing efficiency in research and production environments.
Ginolis's top competitors include Opentrons, Tecan and Andrew Alliance.
Ginolis offers PMBi Dispensing Pump, Cecilia-L Dispenser, Ginolis LFDA-1, and Kaiku Data Collection Service.
Ginolis has 4 investors. Key investors include CELLINK, European Union, Verso Capital, and Springvest.
Ginolis operates through Ginolis Oy.
Yes. Ginolis was acquired by CELLINK in February 2021.